Fabian Tenenbaum
2016
In 2016, Fabian Tenenbaum earned a total compensation of $1.4M as Chief Executive Officer and former Chief Financial Officer at Bellerophon Therapeutics.
Compensation breakdown
| Bonus | $187,500 |
|---|---|
| Option Awards | $902,117 |
| Salary | $306,692 |
| Other | $12,439 |
| Total | $1,408,748 |
Tenenbaum received $902.1K in option awards, accounting for 64% of the total pay in 2016.
Tenenbaum also received $187.5K in bonus, $306.7K in salary and $12.4K in other compensation.
Rankings
In 2016, Fabian Tenenbaum's compensation ranked 6,565th out of 14,075 executives tracked by ExecPay. In other words, Tenenbaum earned more than 53.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,565 out of 14,075 | 53rd |
Division Manufacturing | 2,428 out of 5,489 | 56th |
Major group Chemicals And Allied Products | 790 out of 1,895 | 58th |
Industry group Drugs | 604 out of 1,538 | 61st |
Industry Pharmaceutical Preparations | 476 out of 1,176 | 60th |
Source: SEC filing on March 20, 2017.
Tenenbaum's colleagues
We found three more compensation records of executives who worked with Fabian Tenenbaum at Bellerophon Therapeutics in 2016.